Please login to the form below

Not currently logged in
Email:
Password:

Samsung

This page shows the latest Samsung news and features for those working in and with pharma, biotech and healthcare.

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture

Under the deal, Biogen is taking exclusive rights to Samsung Bioepis’ SB11, a biosimilar of Novartis/Roche’s Lucentis (ranibizumab), as well as SB15 which is a version of ... Meanwhile, as a rider to the licensing deal, Biogen has also taken on

Latest news

More from news
Approximately 28 fully matching, plus 69 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    The deal between Merck &Co and Samsung Bioepis has been in place since 2013, when Merck &Co began to work with Samsung Bioepis to produce biosimilars. ... Merck &Co has paid $155m to Samsung Bioepis to cover the investments made so far, plus interest, in

  • The three forces behind the re-imagining of patient care The three forces behind the re-imagining of patient care

    Pharma will need to embrace the extremes of disruption from large technology companies such as Apple, Samsung  and IBM to a small tech start-up, such as the one in Uganda

  • Deal Watch October 2016 Deal Watch October 2016

    For example Samsung Bioepis also based in South Korea, signed a deal with Merck &Co in 2013 for a range of biosimilars including infliximab, trastuzumab and etanercept (Amgen's Enbrel with

  • Wearables: the tangible product of the patient revolution Wearables: the tangible product of the patient revolution

    as those from FitBit, Samsung and Nike – being launched over the past three years. ... This all rides on the success, or otherwise, of firms like Apple and Samsung in getting as many people as possible involved in its big data projects.

  • From measurement to management From measurement to management

    Apple, Samsung, Google and other key players are open and welcoming to pharma companies that want to genuinely partner and move forward together.

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Battle of the Voice Assistants and Voice Search

    At-a-glance crib sheet on how the battle of the voice assistants is shaping up between Amazon, Google, Apple, Microsoft and Samsung. ... The voice assistant battle is hotting up between the major players; Amazon, Google, Apple, Microsoft and Samsung as

  • An agency called Owen An agency called Owen

    At-a-glance crib sheet on how the battle of the voice assistants is shaping up between Amazon, Google, Apple, Microsoft and Samsung.

  • Back from the future – innovation for pharma

    From individual sets on start-up booths, to the full-on VR experience of the Samsung Lounge, immersive experiences were the order of the day. ... Samsung focused on giving you realistic experiences, a rollercoaster ride where the Gear VR headset is

  • CES 2016 report: new technologies that could improve patient care, by Andy Hastie

    Paired with a smartphone app, Samsung’s wellness belt, or “Welt”, monitors your waistline and counts your steps throughout the day.

  • Evolution of the wearable tech revolution

    Considering that the majority of these fall within the health segment, and that tech giants Apple, Google, Microsoft and Samsung are actively moving into this arena, these numbers certainly seem to ... adoption. To specifically overcome this problem, and

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Healthcare in a lockdown
Even if patients are getting enough care during the COVID-19 pandemic, are they getting the right care?...
Love in the Time of Coronavirus
Having gone through 4 stages of coping with covid-19: first disbelief, then humour, then creative ways to deal with isolation, and finally the tragic realisation that lives are being lost...
The other side of … multiple sclerosis
No good comes from excluding patients from having a say in their own care. In fact, improving activation (& outcomes) demands it....

Infographics